Skip to main content

We use cool technologies to treat dangerous cardiac arrhythmias and other disorders.

We are currently focused on treating atrial fibrillation, the most common cardiac arrhythmia which affects over 6 million patients in the US alone, and costs the US economy over $26B annually. Currently, treatments are sub-optimal, and have significant side effects and pain associated with them. By cooling the heart gently, we may be able to terminate this dangerous arrhythmia in a painless manner at a point of care that is better for patients, providers, and the healthcare ecosystem.